QIMR Berghofer

Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study

Abstract

Using a large (N= 25 493) population-based cohort from Queensland, Australia, we compared melanoma survival among cases with a single invasive melanoma only against those who also had a diagnosis of a single in situ melanoma. After adjustment for sex, age, body site, clinicopathological subtype, thickness and ulceration, it was found that there was no difference (P = 0.99) in 10-year melanoma-specific mortality following a diagnosis of an invasive lesion, whether or not an in situ melanoma was also present. We conclude that in situ melanomas do not alter the prognosis of an invasive melanoma.

Authors Youlden, Danny R.; Khosrotehrani, Kiarash; Green, Adele C.; Soyer, H. Peter; Kimlin, Michael G.; Youl, Philippa H.; Aitken, Joanne F.; Baade, Peter D.
Journal AUSTRALASIAN JOURNAL OF DERMATOLOGY
Pages 57-60
Volume 57
Date 1/02/2016
Grant ID 1054038
Funding Body National Health and Medical Research Council Early Career Fellowship
URL http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1111/ajd.12429
Download Article